Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives

References

• Allied market research – nanomaterials market [Internet]. Portland, USA. 2020 [cited 2020 Nov 23]. Available from: https://www.alliedmarketresearch.com/nano-materials-market.
   Google Scholar
• Pulit-Prociak J, Banach M. Silver nanoparticles – a material of the future? Open Chem. 2016;14(1):76–91.
   Web of Science ®Google Scholar
• Bajpai VK, Kamle M, Shukla S, et al. Prospects of using nanotechnology for food preservation, safety, and security. J Food Drug Anal. 2018;26:1201–1214.
   PubMed Web of Science ®Google Scholar
• Kowsalya E, Mosa Christas K, Balashanmugam P, et al. Biocompatible silver nanoparticles/poly(vinyl alcohol) electrospun nanofibers for potential antimicrobial food packaging applications. Food Packag Shelf Life. 2019;21:100379.
   Web of Science ®Google Scholar
• Verma N, Kumar N. Applications of silver nanoparticles in diverse sectors. Int J Nano Dimension. 2019;10:18–36.
   Web of Science ®Google Scholar
• Muthulakshmi L, Rajalu AV, Kaliaraj GS, et al. Preparation of cellulose/copper nanoparticles bionanocomposite films using a bioflocculant polymer as reducing agent for antibacterial and anticorrosion applications. Compos Part B Eng. 2019;175:107177.
   Web of Science ®Google Scholar
• Qiao K, Tian W, Bai J, et al. Application of magnetic adsorbents based on iron oxide nanoparticles for oil spill remediation: a review. J Taiwan Inst Chem Eng. 2019;97:227–236.
   Web of Science ®Google Scholar
• Dadfar SM, Roemhild K, Drude NI, et al. Iron oxide nanoparticles: diagnostic, therapeutic and theragnostic applications. Adv Drug Deliv Rev. 2019;138:302–325.
   PubMed Web of Science ®Google Scholar
• Verma N, Kumar N. Synthesis and biomedical applications of copper oxide nanoparticles: an expanding horizon. ACS Biomater Sci Eng. 2019;5(3):1170–1188.
   PubMed Web of Science ®Google Scholar
• Lee SH, Jun BH. Silver nanoparticles: synthesis and application for nanomedicine. IJMS. 2019;20(4):865.
   Google Scholar
• Barot T, Rawtani D, Kulkarni P. Physicochemical and biological assessment of silver nanoparticles immobilized Halloysite nanotubes-based resin composite for dental applications. Heliyon. 2020;6:e0360.
   Web of Science ®Google Scholar
• Silva LP, Silveira AP, Bonatto CC, et al. Silver nanoparticles as antimicrobial agents. Silver nanoparticles as antimicrobial agents: past, present, and future. In: Nanostructures for antimicrobial therapy. New York (NY): Academic Press; 2017. p. 577–596.
   Google Scholar
• Sánchez-Sanhueza G, Fuentes-Rodríguez D, Bello-Toledo H. Copper nanoparticles as potential antimicrobial agent in disinfecting root canals. A systematic Review. Int J Odontostomat. 2016;10(3):547–554.
   Google Scholar
• Zhang C, Yan L, Wang X, et al. Progress, challenges, and future of nanomedicine. Nano Today. 2020;35:101008.
   Web of Science ®Google Scholar
• WHO (World health Organization). Infectious diseases kill over 17 million people a year: WHO warns of global crisis [Internet]. 2020 [cited 2020 Nov 11]. Available from: https://www.who.int/whr/1996/media_centre/press_release/en/.
   Google Scholar
• WHO (World health Organization). HIV and hepatitis coinfections [Internet]. 2020 [cited 2020 Nov 11]. Available from: https://www.who.int/hiv/topics/hepatitis/hepatitisinfo/en/.
   Google Scholar
• Frank TD, Carter A, Jahagirdar D, et al. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the global burden of diseases, injuries, and risk factors study 2017. Lancet HIV. 2019;6(12):e831–e859.
   PubMed Web of Science ®Google Scholar
• WHO (World health Organization). Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update [Internet]. 2020 [cited 2020 Nov 11]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. 2020.
   Google Scholar
• Kumar M, Kuroda K, Dhangar K, et al. Potential emergence of antiviral-resistant pandemic viruses via environmental drug exposure of animal reservoirs. Environ Sci Technol. 2020;54:8503–8506.
   PubMed Web of Science ®Google Scholar
• Zhang W, Yang H, Behera S, et al. Prophylaxis of respiratory syncytial virus infection with intranasal siRNA-nanoparticles of the NS1 gene In Vivo. J Allergy Clin Immunol. 2005;115(2):S135.
   Google Scholar
• Mazumder S, Dewangan AK, Pavurala N. Enhanced dissolution of poorly soluble antiviral drugs from nanoparticles of cellulose acetate based solid dispersion matrices. Asian J Pharm Sci. 2017;12(6):532–541.
   PubMed Web of Science ®Google Scholar
• Abo-Zeid Y, Urbanowicz RA, Thomson BJ, et al. Enhanced nanoparticle uptake into virus infected cells: could nanoparticles be useful in antiviral therapy? Int J Pharm. 2018;547(1–2):572–581.
   PubMedGoogle Scholar
• Rao L, Wang W, Meng QF, et al. A biomimetic nanodecoy traps zika virus to prevent viral infection and fetal microcephaly development. Nano Lett. 2019;19:2215–2222.
   PubMed Web of Science ®Google Scholar
• Huo M, Wang L, Chen Y, et al. Nanomaterials/microorganism-integrated microbiotic nanomedicine. Nano Today. 2020;32:100854.
   Web of Science ®Google Scholar
• Salleh A, Naomi R, Utami ND, et al. The potential of silver nanoparticles for antiviral and antibacterial applications: a mechanism of action. Nanomaterials (Basel). 2020;10(8):1566.
   PubMedGoogle Scholar
• Alphandéry E. Iron oxide nanoparticles for therapeutic applications. Drug Discovery Today. 2019;25:141–149.
   PubMed Web of Science ®Google Scholar
• Hang X, Peng H, Song H, et al. Antiviral activity of cuprous oxide nanoparticles against Hepatitis C Virus in vitro. J. Virol. Methods. 2015;222:150–157.
   PubMed Web of Science ®Google Scholar
• Dung TTN, Nam VN, Nhan TT, et al. Silver nanoparticles as potential antiviral agents against African swine fever virus. Mater. Res. Express. 2019;6:1250g9.
   Web of Science ®Google Scholar
• Tavakoli A, Hashemzadeh MS. Inhibition of herpes simplex virus type 1 by copper oxide nanoparticles. J Virol Methods. 2020;275:113688.
   PubMed Web of Science ®Google Scholar
• Van Regenmortel MHV. Virus Species. In: Genetics and evolution of infectious dissease. Amsterdam (The Netherlands): Elsevier: 2011. p. 3–19.
   Google Scholar
• Baltimore D. Expression of animal virus genomes. Bacteriol Rev. 1971;35:235–241.
   PubMedGoogle Scholar
• Ruuskanen O, Lahti E, Jennings LC, et al. Viral pneumonia. Lancet. 2011;377(9773):1264–1275.
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Järvinen A. The common cold. Lancet. 2003;361(9351):51–59.
   PubMed Web of Science ®Google Scholar
• Thiberville S-D, Moyen N, Dupuis-Maguiraga L, et al. Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antivir Res. 2013;99(3):345–370.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Kulkarni S, Mukherjee A. Herpes simplex virus: the hostile guest that takes over your home. Front Microbiol. 2020;11:733.
   PubMed Web of Science ®Google Scholar
• Thuener J. Hepatitis A and B infections. Prim Care. 2017;44(4):621–629.
   PubMed Web of Science ®Google Scholar
• Cherry JD, Krogstad P. Enterovirus and parechovirus infections. In Infectious diseases of the fetus and newborn. USA: Elsevier; 2011. p. 756–799.
   Google Scholar
• Yoshimura K. Current status of HIV/AIDS in the ART era. J Infect Chemother. 2017;23(1):12–16.
   PubMed Web of Science ®Google Scholar
• Cone MM, Whitlow CB. Sexually transmitted and anorectal infectious diseases. Gastroenterol Clin North Am. 2013;42(4):877–892.
   PubMed Web of Science ®Google Scholar
• Wu D, Wu T, Liu Q, et al. The SARS-CoV-2 outbreak: what we know. Int J Infect Dis. 2020;94:44–48.
   PubMed Web of Science ®Google Scholar
• Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924.
   PubMed Web of Science ®Google Scholar
• Martinez MA. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob Agents Chemother. 2020;64(5):e00399–20.
   PubMed Web of Science ®Google Scholar
• Gaudreault NN, Madden DW, Wilson WC, et al. African swine fever virus: an emerging DNA arbovirus. Front Vet Sci. 2020;7.
   PubMed Web of Science ®Google Scholar
• Bergmann M, Ballin A, Schulz B, et al. Therapie des akuten viralen Katzenschnupfens. Tierarztl Prax Ausg K Klientiere Heimtiere. 2019;47(02):98–109.
   PubMedGoogle Scholar
• Karst SM, Wobus CE. Viruses in rodent colonies: lessons learned from murine noroviruses. Annu Rev Virol. 2015;2(1):525–548.
   PubMedGoogle Scholar
• Absalón AE, Cortés-Espinosa DV, Lucio E, et al. Epidemiology, control, and prevention of Newcastle disease in endemic regions: Latin America. Trop Anim Health Prod. 2019;51:1033–1048.
   PubMed Web of Science ®Google Scholar
• Yarlagadda SG, Perazella MA. Drug-induced crystal nephropathy: an update. Expert Opin Drug Saf. 2008;7(2):147–158.
   PubMed Web of Science ®Google Scholar
• Yang R, Wei T, Goldberg H, et al. Getting drugs across biological barriers. Adv Mater. 2017;29(37):1606596.
   Web of Science ®Google Scholar
• Wallet C, De Rovere M, Van Assche J, et al. Microglial cells: the main HIV-1 reservoir in the brain. Front Cell Infect Microbiol. 2019;9:362.
   PubMed Web of Science ®Google Scholar
• Cojocaru FD, Botezat D, Gardikiotis I, et al. Nanomaterials designed for antiviral drug delivery transport across biological barriers. Pharmaceutics. 2020;12(2):171.
   PubMed Web of Science ®Google Scholar
• Chamundeeswari M, Jeslin J, Verma ML. Nanocarriers for drug delivery applications. Environ Chem Lett. 2019;17(2):849–865.
   Web of Science ®Google Scholar
• Sun T, Zhang YS, Pang B, et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed. 2014;53:12320–12364.
   PubMed Web of Science ®Google Scholar
• Mitchell MJ, Billingsley MM, Haley RM, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20:101–124.
   PubMed Web of Science ®Google Scholar
• Ivanova N, Gugleva V, Dobreva M, et al. Silver nanoparticles as multi-functional drug delivery systems. Nanomedicines. 2018.
   Google Scholar
• Prasher P, Sharma M, Mudila H, et al. Emerging trends in clinical implications of bio-conjugated silver nanoparticles in drug delivery. Colloids Interface Sci Commun. 2020;35:100244.
   Web of Science ®Google Scholar
• Jelinkova P, Mazumdar A, Pratap V, et al. Nanoparticle-drug conjugates treating bacterial infections. J Control Release. 2019;307:166–185.
   PubMed Web of Science ®Google Scholar
• Rozalen M, Sánchez-Polo M, Fernández-Perales M, et al. Synthesis of controlled-size silver nanoparticles for the administration of methotrexate drug and its activity in colon and lung cancer cells. RSC Adv. 2020;10(18):10646–10660.
   Web of Science ®Google Scholar
• Yu N, Wang X, Qiu L, et al. Bacteria-triggered hyaluronan/AgNPs/gentamicin nanocarrier for synergistic bacteria disinfection and wound healing application. Chem Eng J. 2020;380:122582.
   Web of Science ®Google Scholar
• Li Y, Lin Z, Xu T, et al. Delivery of VP1 siRNA to inhibit the EV71 virus using functionalized silver nanoparticles through ROS-mediated signaling pathways. RSC Adv. 2017;7(3):1453–1463.
   Web of Science ®Google Scholar
• Lin Z, Li Y, Guo M, et al. The inhibition of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with zanamivir. RSC Adv. 2017;7(2):742–750.
   Web of Science ®Google Scholar
• Jana I, Kumbhakar P, Banerjee S, et al. Copper nanoparticle–graphene composite-based transparent surface coating with antiviral activity against influenza virus. ACS Appl Nano Mater. 2021;4(1):352–362.
   Web of Science ®Google Scholar
• Miyauchi M, Sunada K, Hashimoto K. Antiviral effect of visible light-sensitive CuxO/TiO2 photocatalyst. Catalysts. 2020;10(9):1093.
   Web of Science ®Google Scholar
• Maduray K, Parboosing R. Metal nanoparticles: a promising treatment for viral and arboviral infections. Biol Trace Elem Res. 2020;7:1–18.
   Google Scholar
• Chen L, Liang J. An overview of functional nanoparticles as novel emerging antiviral therapeutic agents. Mater Sci Eng C. 2020;112:110924.
   PubMed Web of Science ®Google Scholar
• Elechiguerra JL, Burt JL, Morones JR, et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnology. 2005;3:6.
   PubMedGoogle Scholar
• Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, et al. Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnol. 2010;8:1.
   PubMedGoogle Scholar
• Lara HH, Garza-Treviño EN, Ixtepan-Turrent L, et al. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. J Nanobiotechnol. 2011;9:30.
   PubMed Web of Science ®Google Scholar
• Rai M, Deshmukh SD, Ingle AP, et al. Metal nanoparticles: the protective nanoshield against virus infection. Crit Rev Microbiol. 2016;42(1):46–56.
   PubMed Web of Science ®Google Scholar
• Aderibigbe BA. Metal-based nanoparticles for the treatment of infectious diseases. Molecules. 2017;22(8):1370.
   PubMed Web of Science ®Google Scholar
• Baram-Pinto D, Shukla S, Perkas N, et al. Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug Chem. 2009;20(8):1497–1502.
   PubMed Web of Science ®Google Scholar
• Sun RW, Chen R, Chung NP, et al. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun. 2005;40:5059–5061.
   PubMed Web of Science ®Google Scholar
• Lu L, Sun RW, Chen R, et al. Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther. 2008;13(2):253–262.
   PubMed Web of Science ®Google Scholar
• Mastro MA, Hardy AW, Boasso A, et al. Non-toxic inhibition of HIV-1 replication with silver–copper nanoparticles. Med Chem Res. 2010;19(9):1074–1081.
   Web of Science ®Google Scholar
• Yesilot S, Aydin C. Silver nanoparticles; a new hope in cancer therapy? East J Med. 2019;24:111–116.
   Google Scholar
• Batchelor-McAuley C, Tschulik K, Neumann CCM, et al. Why are silver nanoparticles more toxic than bulk silver? Towards understanding the dissolution and toxicity of silver nanoparticles. Int J Electrochem Sci. 2014;9:1132–1138.
   Web of Science ®Google Scholar
• Azharuddin M, Zhu GH, Das D, et al. A repertoire of biomedical applications of noble metal nanoparticles. Chem Commun. 2019;55(49):6964–6996.
   PubMed Web of Science ®Google Scholar
• Urzedo AL, Gonçalves MC, Nascimento MHM, et al. Cytotoxicity and antibacterial activity of alginate hydrogel containing nitric oxide donor and silver nanoparticles for topical applications. ACS Biomater Sci Eng. 2020;6:2117–2134.
   PubMed Web of Science ®Google Scholar
• Urzedo AL, Gonçalves MC, Nascimento MHM, et al. Multifunctional alginate nanoparticles containing nitric oxide donor and silver nanoparticles for biomedical applications. Mat Scie Eng C- Mater. 2020;112:110933.
   PubMed Web of Science ®Google Scholar
• Huy TQ, Hien Thanh NT, Thuy NT, et al. Cytotoxicity and antiviral activity of electrochemical – synthesized silver nanoparticles against poliovirus. J Virol Methods. 2017;241:52–57.
   PubMed Web of Science ®Google Scholar
• Avilala J, Golla N. Antibacterial and antiviral properties of silver nanoparticles synthesized by marine Actinomycetes. Int J Pharm Sci Res. 2019;10:1223–1228.
   Web of Science ®Google Scholar
• Rodrigues MC, Rolim WR, Viana MM, et al. Biogenic synthesis and antimicrobial activity of silica-coated silver nanoparticles for esthetic dental applications. J Dent. 2020;96:103327.
   PubMed Web of Science ®Google Scholar
• Rolim WR, Pieretti JC, Reno DLS, et al. Antimicrobial activity and cytotoxicity to tumor cells of nitric oxide donor and silver nanoparticles containing PVA/PEG films for topical applications. ACS Appl Mater Interfaces. 2019;11:6589–6604.
   PubMed Web of Science ®Google Scholar
• Iavicoli I, Leso V, Fontana L, et al. Nanoparticle exposure and hormetic dose–responses: an update. IJMS. 2018;19(3):805.
   Google Scholar
• Sreekanth TVM, Nagajyothi PC, Muthuraman P, et al. Ultra-sonication-assisted silver nanoparticles using Panax ginseng root extract and their anti-cancer and antiviral activities. J. Photochem Photobiol B Biol. 2018;188:6–11.
   PubMed Web of Science ®Google Scholar
• Mathew D, Hsu WL. Antiviral potential of curcumin. J Funct Foods. 2018;40:692–699.
   Web of Science ®Google Scholar
• Yang XX, Li CM, Huang CZ. Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. Nanoscale. 2016;8:3040–3048.
   PubMed Web of Science ®Google Scholar
• Morris D, Ansar M, Speshock J, et al. Antiviral and immunomodulatory activity of silver nanoparticles in experimental RSV infection. Viruses-Basel. 2019;11(8):732.
   Web of Science ®Google Scholar
• Sun L, Singh AK, Vig K, et al. Silver nanoparticles inhibit replication of respiratory sincitial virus. J Biomed Biotechnol. 2008;4:149–158.
   Google Scholar
• Li Y, Lin Z, Zhao M, et al. The reversal of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with amantadine. RSC Adv. 2016;6(92):89679–89686.
   Web of Science ®Google Scholar
• Pellet PE, Roizman B. The Herpesviridae: a brief introduction. In: Fields virology. Philadelphia (PA). 2013. p. 2479–2499.
   Google Scholar
• Roizman B, Knipe DM, Whitley RJ. Fields herpes simplex viruses. In: Fields virology. Philadelphia (PA). 2013. p. 2502–2601.
   Google Scholar
• Galdiero S, Falanga A, Vitiello M, et al. Silver nanoparticles as potential antiviral agents. Molecules. 2011;16:8894–8918.
   PubMed Web of Science ®Google Scholar
• Dhanasezhian A, Srivani S, Govindaraju K, et al. Anti-Herpes Simplex Virus (HSV-1 and HSV-2) activity of biogenic gold and silver nanoparticles using seaweed Sargassum wightii. J Mar Sci. 2019;48:1252–1257.
   Google Scholar
• Orłowski P, Kowalczyk A, Tomaszewska E, et al. Antiviral activity of tannic acid modified silver nanoparticles: potential to activate immune response in herpes genitalis. Viruses. 2018;10(10):524.
   PubMed Web of Science ®Google Scholar
• Galdiero S, Rai M, Gade A, et al. Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int J Nanomedicine. 2013;8:4303–4314.
   PubMed Web of Science ®Google Scholar
• Elechiguerra JL, Burt JL, Morones JR, et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol. 2005;29:3–6.
   Google Scholar
• Tsai C-H, Whiteley CG, Lee D-J. Interactions between HIV-1 protease, silver nanoparticles, and specific peptides. J Taiwan Inst Chem Eng. 2019;103:20–32.
   Web of Science ®Google Scholar
• Kumar SD, Singaravelu G, Ajithkumar S, et al. Mangrove-mediated green synthesis of silver nanoparticles with high HIV-1 reverse transcriptase inhibitory potential. J Clust Sci. 2017;28(1):359–367.
   Web of Science ®Google Scholar
• Lara HH, Ixtepan-Turrent L, Garza Treviño EN, et al. Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins. J Nanobiotechnology. 2011;9:38.
   PubMed Web of Science ®Google Scholar
• Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med. 1997;44(9):1303–1312.
   PubMed Web of Science ®Google Scholar
• Mohammed FA, Ao Z, Girilal M, et al. Inactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infection. Int J Nanomedicine. 2012;7:5007–5018.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wen XY, Gao RP. Hepatitis B virus-related liver cirrhosis complicated with dermatomyositis: a case report. WJCC. 2019;7(10):1206–1212.
   PubMed Web of Science ®Google Scholar
• Kanda T, Nakamoto S, Wu S, et al. Direct-acting antivirals and host-targeting agents against the hepatitis A virus. J Clin Transl Hepatol. 2015;3(3):205–210.
   PubMed Web of Science ®Google Scholar
• Haggag EG, Elshamy AM, Rabeh MA, et al. Antiviral potential of green synthesized silver nanoparticles of lampranthus coccineus and malephora lutea. Int J Nanomedicine. 2019;14:6217–6229.
   PubMed Web of Science ®Google Scholar
• Shady NH, Khattab AR, Ahmed S, et al. Hepatitis C virus NS3 protease and helicase inhibitors from Red Sea sponge (Amphimedon) species in green synthesized silver nanoparticles assisted by in silico modeling and metabolic profiling. Int J Nanomedicine. 2020;15:3377–3389.
   PubMed Web of Science ®Google Scholar
• Dey P, Bergmann T, Cuellar-Camacho JL, et al. Multivalent flexible nanogels exhibit broad-spectrum antiviral activity by blocking virus entry. ACS Nano. 2018;12(7):6429–6442.
   PubMed Web of Science ®Google Scholar
• Nguyen NT-P, Nguyen LV-H, Thanh NT, et al. Stabilization of silver nanoparticles in chitosan and gelatin hydrogel and its applications. Mater Lett. 2019;248:241–245.
   Web of Science ®Google Scholar
• Diniz FR, Maia RCAP, Rannier L, et al. Silver nanoparticles-composing alginate/gelatine hydrogel improves wound healing in vivo. Nanomaterials (Basel). 2020;10(2):390.
   Google Scholar
• Moongraksathum B, Chien MY, Chen YW. Antiviral and antibacterial effects of silver-doped TiO2 prepared by the peroxo sol-gel method. J Nanosci Nanotechnol. 2019;19(11):7356–7362.
   PubMed Web of Science ®Google Scholar
• Szymańska E, Orłowski P, Winnicka K, et al. Multifunctional tannic acid/silver nanoparticle-based mucoadhesive hydrogel for improved local treatment of HSV infection: in vitro and in vivo studies. IJMS. 2018;19(2):387.
   Google Scholar
• Sharma V, Kaushik S, Pandit P, et al. Green synthesis of silver nanoparticles from medicinal plants and evaluation of their antiviral potential against chikungunya virus. Appl Microbiol Biotechnol. 2019;103:881–891.
   PubMed Web of Science ®Google Scholar
• Kaushik S, Sharma V, Chhikara S, et al. Anti-chikungunya activity of green synthesized silver nanoparticles using carica papaya leaves in animal cell culture model. Asian J Pharm Clin Res. 2019;12(6):170–174.
   Google Scholar
• Sujitha V, Murugan K, Paulpandi M, et al. Green-synthesized silver nanoparticles as a novel control tool against dengue virus (DEN-2) and its primary vector Aedes aegypti. Parasitol Res. 2015;114(9):3315–3325.
   PubMed Web of Science ®Google Scholar
• Nalini M, Lena M, Sumathi P, et al. Effect of phyto-synthesized silver nanoparticles on developmental stages of malaria vector, Anopheles stephensi and dengue vector. Aedes aegypti Egypt J Basic Appl Sci. 2017;4(3):212–218.
   Google Scholar
• Parthiba E, Manivannan N, Ramanibai R, et al. Green synthesis of silver-nanoparticles from Annona reticulata leaves aqueous extract and its mosquito larvicidal and anti-microbial activity on human pathogens. Biotechnol Rep. 2019;21:e00297.
   Google Scholar
• Parthiban E, Ramachandran M, Jayakumar M, et al. Biocompatible green synthesized silver nanoparticles impact on insecticides resistant developing enzymes of dengue transmitted mosquito vector. SN Appl Sci. 2019;1(10):1282.
   Web of Science ®Google Scholar
• Murugan K, Sanoopa CP, Madhiyazhagan P, et al. Rapid biosynthesis of silver nanoparticles using Crotalaria verrucosa leaves against the dengue vector Aedes aegypti: what happens around? An analysis of dragonfly predatory behaviour after exposure at ultra-low doses. Nat Prod Res. 2016;30(7):826–833.
   PubMed Web of Science ®Google Scholar
• Yen C-W, de Puig H, Tam JO, et al. Multicolored silver nanoparticles for multiplexed disease diagnostics: distinguishing dengue, yellow fever, and Ebola viruses. Lab Chip. 2015;15(7):1638–1641.
   PubMed Web of Science ®Google Scholar
• Speshock JL, Murdock RC, Braydich-Stolle LK, et al. Interaction of silver nanoparticles with Tacaribe virus. J Nanobiotechnol. 2010;8(1):19.
   PubMedGoogle Scholar
• Castro-Mayorga JL, Randazzo W, Fabra MJ, et al. Antiviral properties of silver nanoparticles against norovirus surrogates and their efficacy in coated polyhydroxyalkanoates systems. Food Sci. Technol. 2017;79:503–510.
   Web of Science ®Google Scholar
• Bekele AZ, Gokulan K, Williams KM, et al. Dose and size-dependent antiviral effects of silver nanoparticles on feline calicivirus, a human norovirus surrogate. Foodborne Pathog Dis. 2016;13(5):239–244.
   PubMed Web of Science ®Google Scholar
• Nikaeen G, Abbaszadeh S, Yousefinejad S. Application of nanomaterials in treatment, anti-infection and detection of coronaviruses. Nanomedicine. 2020;15(15):1501–1512.
   PubMed Web of Science ®Google Scholar
• Jeremiah SS, Miyakawa K, Morita T, et al. Potent antiviral effect of silver nanoparticles on SARS-CoV-2. Biochem Biophys Res Commun. 2020;533:195–200.
   PubMed Web of Science ®Google Scholar
• Zachar O. Formulations for COVID-19 early stage treatment via silver nanoparticles inhalation delivery at home and hospital. Sci Prepr. 2020;14.
   Google Scholar
• Sarkar S. Silver Nanoparticles with bronchodilators through nebulisation to treat Covid 19 Patients. J Curr Med Res Opin. 2020;03:449–450.
   Google Scholar
• Balagna C, Perero S, Percivalle E, et al. Virucidal effect against Coronavirus SARS-CoV-2 of a silver nanocluster/silica composite sputtered coating. Open Ceramics. 2020;1:100006.
   Google Scholar
• Tremiliosi G, Simoes L, Minozzi D, et al. Ag nanoparticles-based antimicrobial polycotton fabrics to prevent the transmission and spread of SARS-CoV-2. bioRxiv. 2020;06(26):152520.
   Google Scholar
• Seabra AB, Manosalva N, de Araujo Lima B, et al. Antibacterial activity of nitric oxide releasing silver nanoparticles. J Phys Conf Ser. 2017;838:012031.
   Google Scholar
• Pieretti JC, Rubilar O, Weller RB, et al. Nitric oxide (NO) and nanoparticles – potential small tools for the war against COVID-19 and other human coronavirus infections. Virus Res. 2021;291:198202.
   PubMed Web of Science ®Google Scholar
• Vetchý M. Biological role of copper as an essential trace element in the human organism. Ceska Slov Farm. 2018;67:143–153.
   PubMedGoogle Scholar
• Chen H, Wu J, Wu M, et al. Preparation and antibacterial activities of copper nanoparticles encapsulated by carbon. New Carbon Mater. 2019;34(4):382–389.
   Web of Science ®Google Scholar
• Thiruvengadam M, Chung IM, Gomathi T, et al. Synthesis, characterization and pharmacological potential of green synthesized copper nanoparticles. Bioprocess Biosyst Eng. 2019;42:1769–1777.
   PubMed Web of Science ®Google Scholar
• Baumert T, Berg T, Lim J, et al. Status of direct-acting antiviral therapy for hepatitis C virus infection and remaining challenges. Gastroenterology. 2019;156(2):431–445.
   PubMed Web of Science ®Google Scholar
• Vermehren J, Park JS, Jacobson IM, et al. Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection. J Hepatol. 2018;69(5):1178–1187.
   PubMed Web of Science ®Google Scholar
• Herold BC, WuDunn D, Soltys N, et al. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol. 1991;65(3):1090–1098.
   PubMed Web of Science ®Google Scholar
• Rautemaa R, Helander T, Meri S. Herpes simplex virus 1 infected neuronal and skin cells differ in their susceptibility to complement attack. Immunology. 2002;106(3):404–411.
   PubMed Web of Science ®Google Scholar
• Yugandhar P, Vasavi T, Jayavardhana Rao Y, et al. Cost effective, green synthesis of copper oxide nanoparticles using fruit extract of Syzygium alternifolium (wt.) walp., characterization and evaluation of antiviral activity. J Clust Sci. 2018;29(4):743–755.
   Web of Science ®Google Scholar
• Fujimori Y, Sato T, Hayata T, et al. Novel antiviral characteristics of nanosized copper(I) iodide particles showing inactivation activity against 2009 pandemic H1N1 influenza virus. Appl Environ Microbiol. 2011;78(4):951–955.
   PubMed Web of Science ®Google Scholar
• Horie M, Ogawa H, Yoshida Y, et al. Inactivation and morphological changes of avian influenza virus by copper ions. Arch Virol. 2008;153(8):1467–1472.
   PubMed Web of Science ®Google Scholar
• Li Y, Hong M, Lin Y, et al. Highly sensitive electrochemical immunoassay for H1N1 influenza virus based on copper-mediated amplification. Chem Commun. 2012;48:6562–6564.
   PubMed Web of Science ®Google Scholar
• Mazurkow JM, Yüzbasi NS, Domagala KW, et al. Nano-sized copper (oxide) on alumina granules for water filtration: effect of copper oxidation state on virus removal performance. Environ Sci Technol. 2020;54:1214–1222.
   PubMed Web of Science ®Google Scholar
• Shionoiri N, Sato T, Fujimori Y, et al. Investigation of the antiviral properties of copper iodide nanoparticles against feline calicivirus. J Biosci Bioeng. 2013;113:580–586.
   Web of Science ®Google Scholar
• Liu M, Sunada K, Hashimoto K, et al. Visible-light sensitive Cu(ii)–TiO2 with sustained anti-viral activity for efficient indoor environmental remediation. J Mater Chem A. 2015;3(33):17312–17319.
   Web of Science ®Google Scholar
• Raha S, Mallick R, Basak S, et al. Is copper beneficial for COVID-19 patients? Med Hypotheses. 2020;142:109814.
   PubMed Web of Science ®Google Scholar
• Abdel-Mottaleb Y. In search for effective and safe drugs against SARS-CoV-2: part II] The role of selected salts and organometallics of copper, zinc, selenium, and iodine food supplements. ChemRxiv. 2020.
   Google Scholar
• Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arab J Chem. 2019;12(7):908–931.
   Web of Science ®Google Scholar
• Iravani S, Korbekandi H, Mirmohammadi SV, et al. Synthesis of silver nanoparticles: chemical, physical and biological methods. Res Pharm Sci. 2014;9:385.
   PubMedGoogle Scholar
• Vance ME, Kuiken T, Vejerano EP, et al. Nanotechnology in the real world: redeveloping the nanomaterial consumer products inventory. Beilstein J Nanotechnol. 2015;6:1769–1780.
   PubMed Web of Science ®Google Scholar
• Dziendzikowska K, Gromadzka‐Ostrowska J, Lankoff A, et al. Time‐dependent biodistribution and excretion of silver nanoparticles in male Wistar rats. J Appl Toxicol. 2012;32:920–928.
   PubMed Web of Science ®Google Scholar
• de Brito J, de Lima V, Ansa D, et al. Acute reproductive toxicology after intratesticular injection of silver nanoparticles (AgNPs) in Wistar rats. Nanotoxicology. 2020;14(7):893–907.
   PubMed Web of Science ®Google Scholar
• Dong L, Lai Y, Zhou H, et al. The biodistribution and transformation of nanoparticulate and ionic silver in rat organs in vivo. NanoImpact. 2020;20:100265.
   Web of Science ®Google Scholar
• Narciso L, Coppola L, Lori G, et al. Genotoxicity, biodistribution and toxic effects of silver nanoparticles after in vivo acute oral administration. NanoImpact. 2020;18:100221.
   Web of Science ®Google Scholar
• Huang H, Lai W, Cui M, et al. An evaluation of blood compatibility of silver nanoparticles. Sci Rep. 2016;6:25518.
   PubMed Web of Science ®Google Scholar
• Selvakumar P, Sithara R, Viveka K, et al. Green synthesis of silver nanoparticles using leaf extract of Acalypha hispida and its application in blood compatibility. J Photochem Photobiol B. 2018;182:52–61.
   PubMed Web of Science ®Google Scholar
• Tang H, Xu M, Zhou X, et al. Acute toxicity and biodistribution of different sized copper nano-particles in rats after oral administration. Mat Sci Eng C. 2018;93:649–663.
   PubMed Web of Science ®Google Scholar
• Dey A, Manna S, Adhikary J, et al. Biodistribution and toxickinetic variances of chemical and green Copper oxide nanoparticles in vitro and in vivo. J Trace Elem Med Biol. 2019;55:154–169.
   PubMed Web of Science ®Google Scholar
• Fahmy H, Ali O, Hassan A, et al. Biodistribution and toxicity assessment of copper nanoparticles in the rat brain. J Trace Elem Med Biol. 2020;61:126505.
   PubMed Web of Science ®Google Scholar
• Darge A, Kahsay AG, Hailekiros H. Bacterial contamination and antimicrobial susceptibility patterns of intensive care units medical equipment and inanimate surfaces at Ayder Comprehensive Specialized Hospital, Mekelle, Northern Ethiopia. BMC Research Notes. 2019;12(1):621.
   PubMed Web of Science ®Google Scholar
• Dorresteijn K, Brouwer MC, Jellema K, et al. Bacterial external ventricular catheter-associated infection. Expert Rev anti Infect Ther. 2020;18:219–229.
   PubMed Web of Science ®Google Scholar
• Ledwoch K, Dancer SJ, Otter JA, et al. Beware Biofilm! Dry biofilms containing bacterial pathogens on multiple healthcare surfaces; a multicenter study. J Hosp Infect. 2018;100(3):e47–e56.
   PubMed Web of Science ®Google Scholar
• Mustapha A, Imir T. Detection of multidrug - resistance gram-negative bacteria from hospital sewage in North East. FEM. 2019;5(1):1–7.
   Google Scholar
• Sib E, Lenz-Plet F, Barabasch V, et al. Bacteria isolated from hospital, municipal and slaughterhouse wastewaters show characteristic, different resistance profiles. Sci Tot Environ. 2020;746:140894.
   PubMed Web of Science ®Google Scholar
• Divya M, Kiran GS, Hassan S, et al. Biogenic synthesis and effect of silver nanoparticles (AgNPs) to combat catheter-related urinary tract infections. Biocatal Agric Biotechnol. 2019;18:101037.
   Web of Science ®Google Scholar
• Mala R, Annie Aglin A, Ruby Celsi AS, et al. Foley catheters functionalised with a synergistic combination of antibiotics and silver nanoparticles resist biofilm formation. IET Nanobiotechnol. 2017;11(5):612–620.
   PubMed Web of Science ®Google Scholar
• Wang BB, Quan YH, Xu ZM, et al. Preparation of highly effective antibacterial coating with polydopamine/chitosan/silver nanoparticles via simple immersion. Prog Org Coat. 2020;149:105967.
   Web of Science ®Google Scholar
• Shalom Y, Perelshtein I, Perkas N, et al. Catheters coated with Zn-doped CuO nanoparticles delay the onset of catheter-associated urinary tract infections. Nano Res. 2017;10(2):520–533.
   Web of Science ®Google Scholar
• Szekeres GP, Németh Z, Schrantz K, et al. Copper-coated cellulose-based water filters for virus retention. ACS Omega. 2018;3(1):446–454.
   PubMed Web of Science ®Google Scholar
• Chiome TJ, Srinivasan A. Use of antiviral nanocoating in personal protective wear. Int J Health Allied Sci. 2020;9:S62–S67.
   Google Scholar
• Nam S, Hillyer MB, Condon BD, et al. Silver nanoparticle-infused cotton fiber: durability and aqueous release of silver in laundry water. J Agric Food Chem. 2020;68(46):13241–13240.
   PubMed Web of Science ®Google Scholar
• Kharaghani D, Khan MQ, Shahzad Am Inoue Y, et al. Preparation and in-vitro assessment of hierarchal organized antibacterial breath mask based on polyacrylonitrile/silver (PAN/AgNPs) Nanofiber. Nanomaterials. 2018;8(7):461.
   Web of Science ®Google Scholar
• Zúñiga J, Cortes A. The role of additive manufacturing and antimicrobial polymers in the COVID-19 pandemic. Expert Rev Med Devices. 2020;17(6):477–481.
   PubMed Web of Science ®Google Scholar
• Ahmed MK, Afifi M, Uskoković V. Protecting healthcare workers during COVID-19 pandemic with nanotechnology: a protocol for a new device from Egypt. J Infect Public Heal. 2020;13(9):1243–1246.
   PubMed Web of Science ®Google Scholar
• Meguid SA, Elzaabalawy A. Potential of combating transmission of COVID-19 using novel self-cleaning superhydrophobic surfaces: part I—protection strategies against fomites. Int J Mech Mater Des. 2020;16(3):423–431.
   Web of Science ®Google Scholar
• van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567.
   PubMed Web of Science ®Google Scholar
• Poggio C, Colombo M, Arciola CR, et al. Copper-alloy surfaces and cleaning regimens against the spread of SARS-CoV-2 in dentistry and orthopedics. From fomites to anti-infective nanocoatings. Materials. 2020;13(15):3244.
   PubMed Web of Science ®Google Scholar
• Granata G, Yamaoka T, Pagnanelli F, et al. Study of the synthesis of copper nanoparticles: the role of capping and kinetic towards control of particle size and stability. J Nanopart Res. 2016;18(5):133.
   Web of Science ®Google Scholar
• Cho YM, Mizuta Y, Akagi JI, et al. Size-dependent acute toxicity of silver nanoparticles in mice. J Toxicol Pathol. 2018;31:73–80.
   PubMed Web of Science ®Google Scholar
• Perde-Schrepler M, Florea A, Brie I, et al. Size-dependent cytotoxicity and genotoxicity of silver nanoparticles in cochlear cells in vitro. J Nanomat. 2018;2019:6090259.
   Web of Science ®Google Scholar
• Tortella GR, Rubilar O, Durán N, et al. Silver nanoparticles: toxicity in model organisms as an overview of its hazard for human health and the environment. J Hazard Mat. 2020;390:121974.
   PubMed Web of Science ®Google Scholar
• Ji JH, Jung JH, Kim SS, et al. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol. 2007;19(10):857–871.
   PubMed Web of Science ®Google Scholar
• Piao MJ, Kang KA, Lee IK, et al. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett. 2011;201:92–100.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao Y, Liu Y, et al. Oxidative stress and acute changes in murine brain tissues after nasal instillation of copper particles with different sizes. J Nanosci Nanotechnol. 2014;14(6):4534–4540.
   PubMed Web of Science ®Google Scholar
• Akter M, Sikder MT, Rahman MM, et al. Systematic review on silver nanoparticles-induced cytotoxicity: physicochemical properties and perspectives. J Adv Res. 2018;9:1–16.
   PubMed Web of Science ®Google Scholar
• Ameh T, Sayes CM. The potential exposure and hazards of copper nanoparticles: a review. Environ Toxicol Pharmacol. 2019;71:103220.
   PubMed Web of Science ®Google Scholar
• Anreddy RNR. Copper oxide nanoparticles induces oxidative stress and liver toxicity in rats following oral exposure. Toxicol Rep. 2018;5:903–904.
   PubMed Web of Science ®Google Scholar
• Lai X, Zhao H, Zhang Y, et al. Intranasal delivery of copper oxide nanoparticles induces pulmonary toxicity and fibrosis in C57BL/6 mice. Sci Rep. 2018;8(1):4499.
   PubMedGoogle Scholar
• Budama-Kilinc Y, Cakir-Koc R, Zorlu T, et al. Assessment of nano-toxicity and safety profiles of silver nanoparticles. In Silver nanoparticles - fabrication, characterization and applications. London, UK: IntechOpen; 2018.
   Google Scholar
• Jiang X, Wu Y, Gray P, et al. Influence of gastrointestinal environment on free radical generation of silver nanoparticles and implications for their cytotoxicity. NanoImpact. 2018;10:144–152.
   Web of Science ®Google Scholar
• Durán N, Fávaro WJ, Seabra AB. What do we really know about nanotoxicology of silver nanopartiles in vivo? New aspects, possible mechanisms and perspectives. Curr Nanosci. 2019;15:1–28.
   Google Scholar